{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T02:37:28Z","timestamp":1782787048473,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["PP00P3_157426"],"award-info":[{"award-number":["PP00P3_157426"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030-153164"],"award-info":[{"award-number":["310030-153164"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_173010"],"award-info":[{"award-number":["310030_173010"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12974-017-0919-1","type":"journal-article","created":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T09:25:54Z","timestamp":1500888354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients"],"prefix":"10.1186","volume":"14","author":[{"given":"Patrice H.","family":"Lalive","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Kreutzfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Devergne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imke","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Bruck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Merkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1146-3129","authenticated-orcid":false,"given":"Caroline","family":"Pot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,24]]},"reference":[{"issue":"6","key":"919_CR1","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.smim.2011.08.003","volume":"23","author":"C Pot","year":"2011","unstructured":"Pot C, Apetoh L, Awasthi A, Kuchroo VK. Induction of regulatory Tr1 cells and inhibition of T(H)17 cells by IL-27. Semin Immunol. 2011;23(6):438\u201345.","journal-title":"Semin Immunol"},{"issue":"12","key":"919_CR2","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/ni1541","volume":"8","author":"A Awasthi","year":"2007","unstructured":"Awasthi A, Carrier Y, Peron JP, Bettelli E, Kamanaka M, Flavell RA, et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol. 2007;8(12):1380\u20139.","journal-title":"Nat Immunol"},{"issue":"12","key":"919_CR3","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/ni1540","volume":"8","author":"DC Fitzgerald","year":"2007","unstructured":"Fitzgerald DC, Zhang GX, El-Behi M, Fonseca-Kelly Z, Li H, Yu S, et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol. 2007;8(12):1372\u20139.","journal-title":"Nat Immunol"},{"issue":"5","key":"919_CR4","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.4049\/jimmunol.179.5.3268","volume":"179","author":"DC Fitzgerald","year":"2007","unstructured":"Fitzgerald DC, Ciric B, Touil T, Harle H, Grammatikopolou J, Das Sarma J, et al. Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. J Immunol. 2007;179(5):3268\u201375.","journal-title":"J Immunol"},{"issue":"9","key":"919_CR5","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.4049\/jimmunol.1302246","volume":"195","author":"A Peters","year":"2015","unstructured":"Peters A, Fowler KD, Chalmin F, Merkler D, Kuchroo VK, Pot C. IL-27 induces Th17 differentiation in the absence of STAT1 signaling. J Immunol. 2015;195(9):4144\u201353.","journal-title":"J Immunol"},{"issue":"6","key":"919_CR6","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.bbi.2011.03.007","volume":"25","author":"CM Sweeney","year":"2011","unstructured":"Sweeney CM, Lonergan R, Basdeo SA, Kinsella K, Dungan LS, Higgins SC, et al. IL-27 mediates the response to IFN-beta therapy in multiple sclerosis patients by inhibiting Th17 cells. Brain Behav Immun. 2011;25(6):1170\u201381.","journal-title":"Brain Behav Immun"},{"issue":"9","key":"919_CR7","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1089\/jir.2014.0207","volume":"35","author":"M Severa","year":"2015","unstructured":"Severa M, Rizzo F, Giacomini E, Annibali V, Gafa V, Romano S, et al. IFN-beta therapy regulates TLR7-mediated response in plasmacytoid dendritic cells of multiple sclerosis patients influencing an anti-inflammatory status. J Interf Cytokine Res. 2015;35(9):668\u201381.","journal-title":"J Interf Cytokine Res"},{"key":"919_CR8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jneuroim.2016.07.004","volume":"304","author":"JE Mindur","year":"2017","unstructured":"Mindur JE, Valenzuela RM, Yadav SK, Boppana S, Dhib-Jalbut S, Ito K. IL-27: a potential biomarker for responders to glatiramer acetate therapy. J Neuroimmunol. 2017;304:21\u20138.","journal-title":"J Neuroimmunol"},{"issue":"2","key":"919_CR9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cyto.2011.04.020","volume":"55","author":"S Tanida","year":"2011","unstructured":"Tanida S, Yoshitomi H, Ishikawa M, Kasahara T, Murata K, Shibuya H, et al. IL-27-producing CD14(+) cells infiltrate inflamed joints of rheumatoid arthritis and regulate inflammation and chemotactic migration. Cytokine. 2011;55(2):237\u201344.","journal-title":"Cytokine"},{"issue":"1\u20132","key":"919_CR10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jns.2004.12.013","volume":"232","author":"J Li","year":"2005","unstructured":"Li J, Gran B, Zhang GX, Rostami A, Kamoun M. IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis. J Neurol Sci. 2005;232(1\u20132):3\u20139.","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"919_CR11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brainres.2005.01.100","volume":"1040","author":"Y Sonobe","year":"2005","unstructured":"Sonobe Y, Yawata I, Kawanokuchi J, Takeuchi H, Mizuno T, Suzumura A. Production of IL-27 and other IL-12 family cytokines by microglia and their subpopulations. Brain Res. 2005;1040(1\u20132):202\u20137.","journal-title":"Brain Res"},{"issue":"4","key":"919_CR12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/glia.22948","volume":"64","author":"V Senecal","year":"2016","unstructured":"Senecal V, Deblois G, Beauseigle D, Schneider R, Brandenburg J, Newcombe J, et al. Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: modulation of local immune responses. Glia. 2016;64(4):553\u201369.","journal-title":"Glia"},{"issue":"6","key":"919_CR13","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d. Ann Neurol. 2005;58(6):840\u20136.","journal-title":"Ann Neurol"},{"issue":"8","key":"919_CR14","doi-asserted-by":"crossref","first-page":"e72399","DOI":"10.1371\/journal.pone.0072399","volume":"8","author":"A Wullschleger","year":"2013","unstructured":"Wullschleger A, Kapina V, Molnarfi N, Courvoisier DS, Seebach JD, Santiago-Raber ML, et al. Cerebrospinal fluid interleukin-6 in central nervous system inflammatory diseases. PLoS One. 2013;8(8):e72399.","journal-title":"PLoS One"},{"issue":"2","key":"919_CR15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0165-5728(94)90075-2","volume":"51","author":"L Bo","year":"1994","unstructured":"Bo L, Mork S, Kong PA, Nyland H, Pardo CA, Trapp BD. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J Neuroimmunol. 1994;51(2):135\u201346.","journal-title":"J Neuroimmunol"},{"issue":"5","key":"919_CR16","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/ana.410380514","volume":"38","author":"W Bruck","year":"1995","unstructured":"Bruck W, Porada P, Poser S, Rieckmann P, Hanefeld F, Kretzschmar HA, et al. Monocyte\/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol. 1995;38(5):788\u201396.","journal-title":"Ann Neurol"},{"issue":"1","key":"919_CR17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ana.410350111","volume":"35","author":"W Bruck","year":"1994","unstructured":"Bruck W, Schmied M, Suchanek G, Bruck Y, Breitschopf H, Poser S, et al. Oligodendrocytes in the early course of multiple sclerosis. Ann Neurol. 1994;35(1):65\u201373.","journal-title":"Ann Neurol"},{"issue":"6","key":"919_CR18","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","volume":"47","author":"C Lucchinetti","year":"2000","unstructured":"Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 2000;47(6):707\u201317.","journal-title":"Ann Neurol"},{"key":"919_CR19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev-immunol-032414-112134","volume":"33","author":"H Yoshida","year":"2015","unstructured":"Yoshida H, Hunter CA. The immunobiology of interleukin-27. Annu Rev Immunol. 2015;33:417\u201343.","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"919_CR20","first-page":"564","volume":"36","author":"L Sosvorova","year":"2015","unstructured":"Sosvorova L, Kanceva R, Vcelak J, Kancheva L, Mohapl M, Starka L, et al. The comparison of selected cerebrospinal fluid and serum cytokine levels in patients with multiple sclerosis and normal pressure hydrocephalus. Neuro Endocrinol Lett. 2015;36(6):564\u201371.","journal-title":"Neuro Endocrinol Lett"},{"issue":"20","key":"919_CR21","first-page":"4274","volume":"20","author":"AL Ji","year":"2016","unstructured":"Ji AL, Liu ZH, Chen WW, Huang WJ. The clinical significance of level changes of hs-CRP, IL-10 and TNF for patients with MS during active and relieving period. Eur Rev Med Pharmacol Sci. 2016;20(20):4274\u20136.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"919_CR22","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1074-7613(02)00324-2","volume":"16","author":"S Pflanz","year":"2002","unstructured":"Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity. 2002;16(6):779\u201390.","journal-title":"Immunity"},{"issue":"10","key":"919_CR23","doi-asserted-by":"crossref","first-page":"6121","DOI":"10.4049\/jimmunol.0803646","volume":"182","author":"LW Collison","year":"2009","unstructured":"Collison LW, Pillai MR, Chaturvedi V, Vignali DAA. Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35-and IL-10-dependent manner. J Immunol. 2009;182(10):6121\u20138.","journal-title":"J Immunol"},{"issue":"6","key":"919_CR24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/jir.2012.0086","volume":"33","author":"S Ye","year":"2013","unstructured":"Ye S, Wu J, Zhou L, Lv Z, Xie H, Zheng S. Interleukin-35: the future of hyperimmune-related diseases? J Interf Cytokine Res. 2013;33(6):285\u201391.","journal-title":"J Interf Cytokine Res"},{"issue":"7492","key":"919_CR25","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature12979","volume":"507","author":"P Shen","year":"2014","unstructured":"Shen P, Roch T, Lampropoulou V, O'Connor RA, Stervbo U, Hilgenberg E, et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature. 2014;507(7492):366\u201370.","journal-title":"Nature"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-017-0919-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T09:26:34Z","timestamp":1500888394000},"score":1,"resource":{"primary":{"URL":"http:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-017-0919-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,24]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["919"],"URL":"https:\/\/doi.org\/10.1186\/s12974-017-0919-1","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,24]]},"article-number":"144"}}